XML 38 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Compensation
12 Months Ended
Dec. 31, 2011
Stock Compensation [Abstract]  
Stock Compensation

13. Stock Compensation

Overview

     The Company has stock option and stock incentive plans for employees and non-employee Directors that provide for grants of RSAs, RSUs, and options to purchase shares of Company common stock at exercise prices generally equal to the fair values of such stock at the dates of grant. The Company also maintains a shareholder approved ESPP for the benefit of its employees.

     Under the Company's plans, the Company is currently authorized to grant the following number of shares and the Company has available for grant up to the following number of shares as of December 31, 2011 and 2010:

  Authorized Available for Grant
Plan Shares 2011 2010
1996 Discounted Employee Stock Purchase Plan, as amended 1,900,000 917,000 981,000
2002 Stock Incentive Plan 974,000 7,000 243,000
2004 Employee Stock Incentive Plan 2,100,000 293,000 26,000
2008 Non-Employee Directors Stock Incentive Plan 300,000 88,000 119,000
2009 Employee Stock Incentive Plan 2,000,000 1,037,000 1,560,000
Total 7,274,000 2,342,000 2,929,000

 

     During 2010 the Company amended the 1996 Discounted Employee Stock Purchase Plan to increase the authorized shares under the plan by 1.0 million shares. Upon the exercise of stock options or grants of RSAs, the Company may issue the required shares out of authorized but unissued common stock or out of treasury stock, at management's discretion.

RSAs and RSUs

     In 2011 the Compensation Committee of the Company's Board of Directors authorized grants of RSAs and RSUs from approved stock incentive plans to non-employee Directors and certain Company executives, officers, and employees totaling 421,000 shares of common stock, which had an aggregate market value of $2.2 million.

     In 2010 the Compensation Committee of the Company's Board of Directors authorized grants of RSAs and RSUs from approved stock incentive plans to non-employee Directors and certain Company executives, officers, and employees totaling 278,000 shares of common stock, which had an aggregate market value of $1.7 million.

     In 2009 the Compensation Committee of the Company's Board of Directors authorized grants of RSAs from approved stock incentive plans to non-employee Directors and certain Company executives and officers totaling 160,000 shares of common stock, which had an aggregate market value of $1.1 million.

A summary of stock grant activity for the years ended December 31, 2011, 2010, and 2009 is as follows:

        Weighted
        Average
        Grant Date
RSAs Shares     Fair Value
Unvested at December 31, 2008 152,000   $ 9.50
Granted 160,000     6.77
Vested (45,000 )   10.62
Unvested at December 31, 2009 267,000     7.67
Granted 219,000     5.93
Vested (122,000 )   6.34
Unvested at December 31, 2010 364,000     7.07
Granted 360,000     5.18
Vested (128,000 )   7.28
Forfeited (44,000 )   5.48
Unvested at December 31, 2011 552,000     5.91

 

        Weighted    
        Average    
        Remaining   Aggregate
        Contractual   Intrinsic
RSUs   Shares   Term in Years   Value
Outstanding at December 31, 2009 - -   - $ -
Granted   58,000        
Outstanding at December 31, 2010   58,000   1.85   313,000
Granted   61,000        
Vested   (19,000 )      
Forfeited   (3,000 )      
Outstanding at December 31, 2011   97,000   1.66   466,000
 
Vested and expected to vest   90,000   1.66   432,000

 

Stock Options

     The Compensation Committee of the Company's Board of Directors authorized grants of stock options from approved stock incentive plans to certain Company executives and employees totaling 599,000, 451,000, and 438,000 shares in 2011, 2010, and 2009, respectively, with exercise prices equal to the stock prices on the respective grant dates.

A summary of the Company's stock option activity for the years ended December 31, 2011, 2010, and 2009 follows:
          Weighted    
          Average    
        Weighted Remaining   Aggregate
        Average Contractual   Intrinsic
  Shares     Exercise Price Term in Years   Value
Outstanding at December 31, 2008 1,773,000   $ 7.23 3.63 $ 7,174,000
Granted 438,000     4.83      
Exercised (134,000 )   5.08      
Forfeited (26,000 )   5.62      
Expired (64,000 )   5.50      
Outstanding at December 31, 2009 1,987,000     6.92 3.59   1,731,000
Granted 451,000     6.96      
Exercised (4,000 )   4.49      
Forfeited (15,000 )   6.11      
Expired (138,000 )   10.20      
Outstanding at December 31, 2010 2,281,000     6.74 3.46   603,000
Granted 599,000     5.13      
Exercised (260,000 )   4.53      
Forfeited (100,000 )   5.60      
Expired (320,000 )   5.30      
Outstanding at December 31, 2011 2,200,000     6.83 4.00   -
 
Vested and expected to vest 2,163,000     6.85 3.96   -
Exercisable at December 31, 2011 1,249,000     7.72 2.84   -

 

Other information concerning stock options for the years ended December 31 is as follows:

    2011   2010   2009
Weighted-average fair value of options granted $ 2.54 $ 3.34 $ 2.40
Intrinsic value of options exercised   261,000   10,000   274,000

 

     Employees purchased common stock totaling 64,000, 43,000, and 79,000 shares in 2011, 2010, and 2009, respectively, through the Company's ESPP.

Stock Compensation Expense

The following weighted-average assumptions were used to determine the fair value of options:

  2011 2010 2009
  Stock   ESPP   Stock   ESPP   Stock     ESPP  
  Options   Options   Options   Options   Options     Options  
Expected life of options 4.0 Years   .50 Years   3.8 Years   .38 Years   4.0 Years     .25 Years  
Expected stock price volatility .65   .39   .65   .47   .65     .75  
Risk-free interest rate 1.25 % 0.14 % 1.25 % 0.17 % 1.51 %   0.14 %

 

The following table summarizes stock compensation expenses (in thousands):

    2011   2010   2009
RSA and RSU expense $ 1,408 $ 970 $ 899
Stock option and ESPP option expense   1,606   1,950   1,780
Total stock compensation expense $ 3,014 $ 2,920 $ 2,679

 

     Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, and stock options issued in each respective year as well as those issued in prior periods that continue to vest during the period, and compensation related to the Company's ESPP. These amounts were recorded as stock compensation expense and were subject to the Company's normal allocation of expenses to deferred preservation costs and inventory costs. The Company capitalized $224,000, $299,000, and $250,000 in the years ended December 31, 2011, 2010, and 2009, respectively, of the stock compensation expense included in the table above into its deferred preservation costs and inventory costs.

     As of December 31, 2011 the Company had a total of $2.1 million in total unrecognized compensation costs related to unvested RSAs and RSUs, before considering the effect of expected forfeitures. As of December 31, 2011 this expense is expected to be recognized over a weighted-average period of 1.4 years for RSAs and 2.5 years for RSUs. As of December 31, 2011 there was approximately $1.7 million in total unrecognized compensation costs related to unvested stock options, before considering the effect of expected forfeitures. As of December 31, 2011 this expense is expected to be recognized over a weighted-average period of 1.6 years.